173 related articles for article (PubMed ID: 34270462)
1. Expression mode and prognostic value of FXYD family members in colon cancer.
Jin M; Zhang H; Yang J; Zheng Z; Liu K
Aging (Albany NY); 2021 Jul; 13(14):18404-18422. PubMed ID: 34270462
[TBL] [Abstract][Full Text] [Related]
2. The roles of FXYD family members in ovarian cancer: an integrated analysis by mining TCGA and GEO databases and functional validations.
Zhao E; Gao K; Xiong J; Liu Z; Chen Y; Yi L
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17269-17284. PubMed ID: 37814066
[TBL] [Abstract][Full Text] [Related]
3. FXYD proteins stabilize Na,K-ATPase: amplification of specific phosphatidylserine-protein interactions.
Mishra NK; Peleg Y; Cirri E; Belogus T; Lifshitz Y; Voelker DR; Apell HJ; Garty H; Karlish SJ
J Biol Chem; 2011 Mar; 286(11):9699-712. PubMed ID: 21228272
[TBL] [Abstract][Full Text] [Related]
4. Expression Profile and Prognostic Values of
Li J; Ye M; Zhou C
Front Oncol; 2020; 10():368. PubMed ID: 32296636
[TBL] [Abstract][Full Text] [Related]
5. [FXYD proteins: novel regulators of Na,K-ATPase].
Delprat B; Bibert S; Geering K
Med Sci (Paris); 2006; 22(6-7):633-8. PubMed ID: 16828040
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of SLC4A4 and its Correlation with Immune Infiltration in Colon Adenocarcinoma.
Chen X; Chen J; Feng Y; Guan W
Med Sci Monit; 2020 Sep; 26():e925016. PubMed ID: 32949121
[TBL] [Abstract][Full Text] [Related]
7. Function of FXYD proteins, regulators of Na, K-ATPase.
Geering K
J Bioenerg Biomembr; 2005 Dec; 37(6):387-92. PubMed ID: 16691470
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analyses of the heterogeneity and prognostic significance of tumor-infiltrating immune cells in non-small-cell lung cancer: Development and validation of an individualized prognostic model.
Pang Z; Chen X; Wang Y; Wang Y; Yan T; Wan J; Du J
Int Immunopharmacol; 2020 Sep; 86():106744. PubMed ID: 32623229
[TBL] [Abstract][Full Text] [Related]
9. FXYD proteins: new tissue- and isoform-specific regulators of Na,K-ATPase.
Geering K; Béguin P; Garty H; Karlish S; Füzesi M; Horisberger JD; Crambert G
Ann N Y Acad Sci; 2003 Apr; 986():388-94. PubMed ID: 12763855
[TBL] [Abstract][Full Text] [Related]
10. FXYD proteins: new regulators of Na-K-ATPase.
Geering K
Am J Physiol Renal Physiol; 2006 Feb; 290(2):F241-50. PubMed ID: 16403837
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
Yang KS; Xu CQ; Lv J
Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
[TBL] [Abstract][Full Text] [Related]
12. Structural and functional interaction sites between Na,K-ATPase and FXYD proteins.
Li C; Grosdidier A; Crambert G; Horisberger JD; Michielin O; Geering K
J Biol Chem; 2004 Sep; 279(37):38895-902. PubMed ID: 15234969
[TBL] [Abstract][Full Text] [Related]
13. Identification of FXYD protein genes in a teleost: tissue-specific expression and response to salinity change.
Tipsmark CK
Am J Physiol Regul Integr Comp Physiol; 2008 Apr; 294(4):R1367-78. PubMed ID: 18256141
[TBL] [Abstract][Full Text] [Related]
14. High expression of PLAC1 in colon cancer as a predictor of poor prognosis: A study based on TCGA data.
Ren Y; Lv Y; Li T; Jiang Q
Gene; 2020 Dec; 763():145072. PubMed ID: 32827679
[TBL] [Abstract][Full Text] [Related]
15. FXYD proteins reverse inhibition of the Na+-K+ pump mediated by glutathionylation of its beta1 subunit.
Bibert S; Liu CC; Figtree GA; Garcia A; Hamilton EJ; Marassi FM; Sweadner KJ; Cornelius F; Geering K; Rasmussen HH
J Biol Chem; 2011 May; 286(21):18562-72. PubMed ID: 21454534
[TBL] [Abstract][Full Text] [Related]
16. Identifying a new microRNA signature as a prognostic biomarker in colon cancer.
Lv Y; Duanmu J; Fu X; Li T; Jiang Q
PLoS One; 2020; 15(2):e0228575. PubMed ID: 32049961
[TBL] [Abstract][Full Text] [Related]
17. Structural interactions between FXYD proteins and Na+,K+-ATPase: alpha/beta/FXYD subunit stoichiometry and cross-linking.
Lindzen M; Gottschalk KE; Füzesi M; Garty H; Karlish SJ
J Biol Chem; 2006 Mar; 281(9):5947-55. PubMed ID: 16373350
[TBL] [Abstract][Full Text] [Related]
18. Expression profile and prognostic values of SMC family members in HCC.
Yan W; Wang DD; Zhang HD; Huang J; Hou JC; Yang SJ; Zhang J; Lu L; Zhang Q
Medicine (Baltimore); 2022 Oct; 101(42):e31336. PubMed ID: 36281130
[TBL] [Abstract][Full Text] [Related]
19. DNM1: A Prognostic Biomarker Associated with Immune Infiltration in Colon Cancer-A Study Based on TCGA Database.
Hu M; Gu J; Su W; Zhang Z; Zhu B; Wang Q; Xing C
Biomed Res Int; 2021; 2021():4896106. PubMed ID: 34888380
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic values of C‑X‑C motif chemokine ligand 3 in patients with colon cancer.
Ruan GT; Gong YZ; Liao XW; Wang S; Huang W; Wang XK; Zhu GZ; Liao C; Gao F
Oncol Rep; 2019 Nov; 42(5):1996-2008. PubMed ID: 31545503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
